Pratik Shah is a highly successful biotech entrepreneur serving as Chairman and CEO of Design Therapeutics. He has a notable history of leading companies to significant acquisitions, including Auspex Pharmaceuticals and Synthorx. He holds both a Ph. D. in Chemistry and an MBA from the University of Chicago.
Beyond his executive roles, Pratik maintains a strong connection with his alma mater, the University of Chicago. He keeps up with financial and business news, following publications like The Wall Street Journal to stay informed on market trends and economic developments.
Unique fact: Dr. Shah is a prolific inventor, named as a co-inventor on over 100 patents.
Pratik Shah
Chairman and CEO at Design Therapeutics
Carlsbad, California, United States
Overview
Topics They Care About
Biotech Ventures
He has a proven track record of founding and leading biotech companies, like Auspex and Synthorx, to successful, multi-billion dollar exits.
Drug Development
His career is focused on advancing novel therapeutics, recently celebrating the FDA approval of "neffy" while serving as Chairman at ARS Pharmaceuticals.
Scientific Innovation
With a Ph. D. in Chemistry, over 20 scientific publications, and more than 100 patents, he is deeply rooted in the science behind his ventures.
Media Appearances
Work History
8-2023
Chairman and CEO at Design Therapeutics
10-2018 - 3-2020
Chairman Of The Board at Synthorx Inc
11-2017 - 8-2023
Executive Chairman at Design Therapeutics
3-2016
Chairman at ARS Pharmaceuticals, Inc.
10-2013 - 7-2015
President and CEO at Auspex Pharmaceuticals
2004 - 2014
Partner at Thomas, McNerney and Partners
2001 - 2004
Chief Business Officer and Co-founder at Kalypsys
1999 - 2001
Consultant at McKinsey & Company
Education
1997 - 1999
MBA from University of Chicago
1991 - 1996
Ph.D. from University of Chicago
More Information
Social Presence :
Prographics :
Exp : 23
Location : Carlsbad, California, United States
Job Level : Leadership
Designation : Chairman and CEO at Design Therapeutics
